TipRanks
Pediatrix Medical Group (CH:PDC)
:PDC
Switzerland Market
PDC
Pediatrix Medical Group
RESEARCH TOOLSreports

Pediatrix Medical Group (PDC) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

PDC Analyst Ratings

Hold
6Ratings
Hold
1 Buy
5 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Pediatrix
Medical Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PDC Stock 12 Month Forecast

Average Price Target

―
Based on 6 Wall Street analysts offering 12 month price targets for Pediatrix Medical Group in the last 3 months. The average price target is CHF22.49 with a high forecast of CHF22.98 and a low forecast of CHF20.52. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF22.98Average Price TargetCHF22.49Lowest Price TargetCHF20.52
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:PDC
Jack Slevin
Jefferies
Jefferies
CHF22.16→CHF22.98
Hold
―
Downgraded
08/19/26
Pediatrix Medical downgraded to Hold from Buy at JefferiesPediatrix Medical downgraded to Hold from Buy at Jefferies
Mizuho Securities Analyst forecast on CH:PDC
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF22.16→CHF22.98
Hold
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: 908 Devices (NASDAQ: MASS), Pediatrix Medical Group (NYSE: MD) and BridgeBio Oncology Therapeutics (NASDAQ: BBOT)
UBS Analyst forecast on CH:PDC
A.J. Rice
UBS
UBS
CHF20.52→CHF22.98
Hold
―
Reiterated
08/06/26
UBS Keeps Their Hold Rating on Pediatrix Medical Group (MD)
Truist Financial Analyst forecast on CH:PDC
David S Macdonald
Truist Financial
Truist Financial
CHF22.98
Hold
―
Reiterated
08/05/26
Truist Financial Reaffirms Their Hold Rating on Pediatrix Medical Group (MD)
Deutsche Bank Analyst forecast on CH:PDC
Pito Chickering
Deutsche Bank
Deutsche Bank
CHF15.6→CHF20.52
Hold
―
Assigned
08/05/26
Pediatrix Medical price target raised to $25 from $19 at Deutsche BankPediatrix Medical price target raised to $25 from $19 at Deutsche Bank
William Blair Analyst forecast on CH:PDC
Ryan Daniels
William Blair
William Blair
―
Buy
―
Reiterated
08/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Pediatrix Medical Group (NYSE: MD), Certara (NASDAQ: CERT) and Gilead Sciences (NASDAQ: GILD)
Leerink Partners Analyst forecast on CH:PDC
Whit Mayo
Leerink Partners
Leerink Partners
CHF13.95
Hold
―
Reiterated
10/03/25
Leerink Partners Sticks to Their Hold Rating for Pediatrix Medical Group (MD)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:PDC
Jack Slevin
Jefferies
Jefferies
CHF22.16→CHF22.98
Hold
―
Downgraded
08/19/26
Pediatrix Medical downgraded to Hold from Buy at JefferiesPediatrix Medical downgraded to Hold from Buy at Jefferies
Mizuho Securities Analyst forecast on CH:PDC
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF22.16→CHF22.98
Hold
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: 908 Devices (NASDAQ: MASS), Pediatrix Medical Group (NYSE: MD) and BridgeBio Oncology Therapeutics (NASDAQ: BBOT)
UBS Analyst forecast on CH:PDC
A.J. Rice
UBS
UBS
CHF20.52→CHF22.98
Hold
―
Reiterated
08/06/26
UBS Keeps Their Hold Rating on Pediatrix Medical Group (MD)
Truist Financial Analyst forecast on CH:PDC
David S Macdonald
Truist Financial
Truist Financial
CHF22.98
Hold
―
Reiterated
08/05/26
Truist Financial Reaffirms Their Hold Rating on Pediatrix Medical Group (MD)
Deutsche Bank Analyst forecast on CH:PDC
Pito Chickering
Deutsche Bank
Deutsche Bank
CHF15.6→CHF20.52
Hold
―
Assigned
08/05/26
Pediatrix Medical price target raised to $25 from $19 at Deutsche BankPediatrix Medical price target raised to $25 from $19 at Deutsche Bank
William Blair Analyst forecast on CH:PDC
Ryan Daniels
William Blair
William Blair
―
Buy
―
Reiterated
08/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Pediatrix Medical Group (NYSE: MD), Certara (NASDAQ: CERT) and Gilead Sciences (NASDAQ: GILD)
Leerink Partners Analyst forecast on CH:PDC
Whit Mayo
Leerink Partners
Leerink Partners
CHF13.95
Hold
―
Reiterated
10/03/25
Leerink Partners Sticks to Their Hold Rating for Pediatrix Medical Group (MD)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
CELCCelcuity
ONCBeOne Medicines
GHGuardant Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pediatrix Medical Group

3 Months
OpenAI Medical - Care FacilitiesTipRanks - OpenAI
Success Rate
2/3 ratings generated profit
67%
Average Return
+15.67%
Copying OpenAI Medical - Care Facilities's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +15.67% per trade.
1 Year
OpenAI Medical - Care FacilitiesTipRanks - OpenAI
Success Rate
3/3 ratings generated profit
100%
Average Return
+18.07%
Copying OpenAI Medical - Care Facilities's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +18.07% per trade.
2 Years
OpenAI Medical - Care FacilitiesTipRanks - OpenAI
Success Rate
3/3 ratings generated profit
100%
Average Return
+18.07%
Copying OpenAI Medical - Care Facilities's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +18.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PDC Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
2
2
1
1
1
Hold
4
4
5
7
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
6
6
8
8
In the current month, PDC has received 1 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. PDC average Analyst price target in the past 3 months is 22.49.
Each month's total comprises the sum of three months' worth of ratings.

PDC Financial Forecast

PDC Earnings Forecast

Next quarter’s earnings estimate for PDC is CHF0.54 with a range of CHF0.52 to CHF0.55. The previous quarter’s EPS was CHF0.52. PDC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PDC has Performed in-line its overall industry.
Next quarter’s earnings estimate for PDC is CHF0.54 with a range of CHF0.52 to CHF0.55. The previous quarter’s EPS was CHF0.52. PDC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PDC has Performed in-line its overall industry.

PDC Sales Forecast

Next quarter’s sales forecast for PDC is CHF412.63M with a range of CHF409.25M to CHF418.44M. The previous quarter’s sales results were CHF404.02M. PDC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PDC has Performed in-line its overall industry.
Next quarter’s sales forecast for PDC is CHF412.63M with a range of CHF409.25M to CHF418.44M. The previous quarter’s sales results were CHF404.02M. PDC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PDC has Performed in-line its overall industry.

PDC Stock Forecast FAQ

What is CH:PDC’s average 12-month price target, according to analysts?
Based on analyst ratings, Pediatrix Medical Group’s 12-month average price target is 22.49.
    What is CH:PDC’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:PDC, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Pediatrix Medical Group a Buy, Sell or Hold?
        Pediatrix Medical Group has a consensus rating of Hold, which is based on 1 buy ratings, 5 hold ratings and 0 sell ratings.
          What is Pediatrix Medical Group’s share price target?
          The average share price target for Pediatrix Medical Group is 22.49. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF22.98 ,and the lowest forecast is CHF20.52. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Pediatrix Medical Group?
            Pediatrix Medical Group’s analyst rating consensus is a Hold. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of Pediatrix Medical Group?
              To buy shares of CH:PDC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.